Hepatic Veno-Occlusive Disease in a Case of Polymyositis Associated with Thrombotic Thrombocytopenic Purpura/hemolytic Uremic Syndrome

Internal Medicine

Volumn 37, Issue 8, 1998, Pages 694-699

  Ishida, Yoh Ichi ^a   Utikoshi, Manabu ^a   Kurosaki, Masao ^a   Ohta, Katuroh ^a   Chujo, Tatsuya ^a   Aoyama, Shou ^a   Ohsawa, Kenzo ^a   Saito, Katsuhiko ^a   Yokoyama, Hitoshi ^b   Ohta, Satoshi ^b  

^a TOYAMA CITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Ascites; Autoimmune disease; Endothelium; Plasma exchange

Indexed keywords

ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ARTICLE; CASE REPORT; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; LIVER VEIN OBSTRUCTION; MIDDLE AGED; PATHOLOGY; PLASMAPHERESIS; POLYMYOSITIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTI-INFLAMMATORY AGENTS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MIDDLE AGED; PLASMA EXCHANGE; POLYMYOSITIS; PREDNISOLONE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0032132681     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.694     Document Type: Article

References (24)

1. Rollins BJ. Hepatic veno-occlusive disease. Am J Med 81: 297, 1986.
2. Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79: 1178, 1980.
3. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 10: 197, 1992.
4. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118: 255, 1993.
5. Wanless IR. Vascular disorders, in: Pathology of the Liver. MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, Eds. Churchill Livingstone, Edinburgh, 1994, p. 535.
6. Alpert LI. Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of literature. Hum Pathol 7: 709, 1976.
7. Mellis C, Bale PM. Familial hepatic veno-occlusive disease with probable immune deficiency. J Pediatr 88: 236, 1976.
8. Pappas SC, Malone DG, Rabin L, Hoofnagle JH. Jones EA. Hepatic venoocclusive disease in a patient with systemic lupus erythematosus. Arthritis Rheum 27: 104, 1984.
9. Buckley JA, Hutchins GM. Association of hepatic veno-occlusive disease with the acquired immunodeficiency syndrome. Mod Pathol 8: 398, 1995.
10. McLeod BC, Wu KK, Knospe WH. Plasmapheresis in thrombotic thrombocytopenic purpura. Arch Intern Med 140: 1059, 1980.
11. Sawdyk MA, Jundt J. Dermatomyositis complicated by thrombotic thrombocytopenic purpura. Henry Ford Hosp Med J 33: 214, 1985.
12. Noda M, Kitagawa M, Tomoda F, Iida H. Thrombotic thrombocytopenic purpura as a complicating factor in a case of polymyositis and Sjögren's syndrome. Am J Clin Pathol 94: 217, 1990.
13. Ellingson TL, Wilske K, Aboulatia DM. Case report: thrombotic thrombocytopenic purpura in a patient with polymyositis: therapeutic importance of early recognition and discussion of pathogenic mechanisms. Am J Med SCi 303: 407, 1992.
14. Saito Y, Hamamura K, Kurata Y, Sugimoto T. A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura (TTP) which responded to combination of gamma globulin and vincristine - clinical analysis on TTP cases in the Japanese literatures. Rinsho Ketsueki (Jpn J Clin Hematol) 34: 68, 1993 (Abstract in English).
15. Makino H, Nagake Y, Moriwaki K, et al. Thrombotic thrombocytopenic purpura and myoglobinuric acute renal failure following radiation therapy in a patient with polymyositis and cervical cancer. Intern Med 34: 24, 1995.
16. Miyaoka Y, Urano Y, Nameda Y, et al. A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura. Dermatology 194: 68, 1997.
17. Bisogno G, de Kraker J, Weirich A, et al. Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol 29: 245, 1997.
18. Ortega JA, Donaldson SS, Ivy SP, Pappo A, Maurer HM and Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Cancer 79: 2435, 1997.
19. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14: 495, 1994.
20. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blockingendomysial deposition of activated complement fragments. J Clin Invest 94: 1729, 1994.
21. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155: 1434, 1995.
22. Kawana S. The membrane attack complex of complement alters the membrane integrity of cultured endothelial cells: a possible pathophysiology for immune complex vasculitis. Acta Derm Venereol 76: 13, 1996.
23. Tateyama M, Nagano I, Yoshioka M, Chida K, Nakamura S, Itoyama Y. Expression of tumor necrosis factor-alpha in muscles of polymyositis. J Neurol Sci 146: 45, 1997.
24. Lundberg I. Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 40: 865, 1997.